Antiparasitic Drugs Global Market Report 2024

Description

“Antiparasitic Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antiparasitic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antiparasitic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The antiparasitic drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: Anthelmintics; Antiprotozoals; Ectoparasiticide; Other Products
2) By Treatment: Avermectins; Bezimidazoles; Pyrimidines; Organophosphates; Imidazolesthiazoles
3) By Route of Administration: Oral; Injectable; Topical
4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Cadila Pharmaceuticals; Merck & Co.Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Antiparasitic drugs encompass a category of medications designed to combat infections triggered by a variety of parasites that have the potential to infest humans, animals, or plants. Parasites are living organisms that either reside on or within a host organism, drawing sustenance from it and often causing harm in the process. Antiparasitic drugs are formulated to specifically target these parasites, either by exterminating them or inhibiting their growth.

The primary product categories within antiparasitic drugs include anthelmintics, antiprotozoals, ectoparasiticides, and other related treatments. Anthelmintics, for instance, are a class of drugs tailored to address infections caused by parasitic worms. They operate by either eradicating the parasites or stunting their growth and reproductive capabilities. A diverse range of treatments falls under this category, including avermectins, benzimidazoles, pyrimidines, organophosphates, and imidazole thiazoles. These treatments can be administered through various means, such as orally, through injections, or topically, and are employed across a spectrum of end-users, including hospitals, homecare settings, specialty clinics, and others.

The antiparasitic drugs market research report is one of a series of new reports from The Business Research Company that provides antiparasitic drugs market statistics, including antiparasitic drugs industry global market size, regional shares, competitors with an antiparasitic drugs market share, detailed antiparasitic drugs market segments, market trends and opportunities and any further data you may need to thrive in the antiparasitic drugs industry. This antiparasitic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antiparasitic drugs market size has grown strongly in recent years. It will grow from $22.47 billion in 2023 to $24.06 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to prevalence of parasitic infections, resistance to existing treatments, global health initiatives, .

The antiparasitic drugs market size is expected to see strong growth in the next few years. It will grow to $31.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to emerging parasitic threats, climate change and vector-borne diseases, increased emphasis on global health security, access to healthcare. Major trends in the forecast period include advances in drug development, targeted therapies, combination therapies, public-private partnerships, telemedicine and remote diagnosis.

The escalating incidence of vector-borne diseases is set to be a catalyst for the growth of the antiparasitic drugs market in the coming years. Vector-borne diseases, characterized by their transmission to humans and other animals through arthropod bites, primarily by insects such as mosquitoes, ticks, and flies, are on the rise. Notable examples of vector-borne diseases encompass malaria, dengue, and yellow fever. Antiparasitic drugs play a pivotal role in curbing the proliferation of these diseases by selectively targeting and eradicating the responsible parasites. Several antiparasitic medications, including chloroquine, doxycycline, and atovaquone-proguanil, are widely used in the treatment of malaria. For instance, in August 2023, data from the Pan American Health Organization, a US-based specialized agency of the United Nations, reported a substantial increase in dengue cases in the United States during the year. The number of new infections surpassed 3 million, surpassing the figures recorded in 2019, a year that witnessed the highest incidence in the region, with 3.1 million cases, including 28,203 severe cases and 1,823 fatalities.Additionally, in December 2022, according to the World Malaria Report 2022 published by the World Health Organization, a Switzerland-based intergovernmental organization, a total of 247 million malaria cases were documented globally in 2021, slightly higher than the 245 million cases reported in 2020. Consequently, the growing occurrence of vector-borne diseases is a driving force behind the expansion of the antiparasitic drugs market.

The substantial prevalence of parasitic infections is poised to propel the expansion of the antiparasitic drug market. Parasitic infections are caused by microscopic parasites or larger organisms that inhabit and flourish at the expense of their host, often leading to harm or disease. Antiparasitic drugs play a vital role in the prevention and management of these parasitic infections, contributing to enhanced health outcomes and a reduction in the burden of these diseases on affected individuals and communities. For instance, in August 2021, data from the National Library of Medicine, a medical library operated by the US federal government, revealed that among 136 participants in a study, 46.3% of them were found to have intestinal parasites. The most commonly encountered parasite was Entamoeba histolytica, affecting 33.3% (21 out of 63), while the least prevalent was Giardia lamblia, impacting 11.1% (7 out of 63). Hence, the high prevalence of parasitic infections is a driving factor behind the growth of the antiparasitic drug market.

The increasing resistance to antimalarial drug regimens poses a significant challenge and potential restraint on the market's growth in the foreseeable future. Antimalarial medications are facing higher resistance rates compared to other antiparasitic drugs, which may impact the development of combination treatments that are both more effective and more costly. These factors could adversely affect market expansion by limiting access to antiparasitic drugs and increasing the overall cost of patient treatment. For instance, in January 2021, as reported by Biomed Central Ltd., a for-profit scientific open access publisher, a study involving the genotyping of 18,706 SNPs related to antimalarial medication resistance indicators, out of 47,382 samples, revealed a pooled prevalence of 35.4% (95% CI 29.1-42.3%). Hence, the mounting resistance to antimalarial drug regimens is impeding the growth of the antiparasitic drugs market.

Prominent companies in the antiparasitic drugs market are committed to advancing innovative products and solutions to maintain their foothold in the industry. Notably, in August 2021, ParaPRO LLC, a pharmaceutical company based in the United States, introduced Natroba Topical Suspension, which achieved a remarkable milestone by becoming the first antiparasitic product (new drug application) to gain approval from the U.S. Food and Drug Administration (FDA) for the treatment of scabies. Natroba's active ingredient, Spinosad, exerts its action on the nervous system of lice, inducing paralysis and ultimately leading to their demise. This treatment is administered topically to the scalp and hair and may often require only a single application. What sets Natroba apart is that Spinosad, its active component, is precisely delivered to the stratum corneum, the outermost layer of the epidermis, allowing it to target mites at the site of infestation without deep penetration into the dermis or entering the systemic circulation.

In June 2022, Orion Corporation, a pharmaceutical company headquartered in Finland, completed the acquisition of Inovet BV's animal health division for $141 million (€130 million). This strategic acquisition is anticipated to bolster Orion Corporation's presence in Western Europe and export markets, and it will also grant them access to a dedicated production facility specializing in the manufacturing of veterinary medicines. Inovet BV, based in Belgium, is a renowned veterinary pharmaceutical company known for its wide range of products, including antiparasitic treatments, antibiotics, and vaccines.

Major players in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd, Alkem Laboratories Ltd, Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.

North America was the largest region in the antiparasitic drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antiparasitic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antiparasitic drugs market consists of sales of antimalarial drugs, antiamoebic drugs, anti-trematode drugs and veterinary products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12273

1. Executive Summary

2. Antiparasitic Drugs Market Characteristics

3. Antiparasitic Drugs Market Trends And Strategies

4. Antiparasitic Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Antiparasitic Drugs Market Size and Growth

5.1. Global Antiparasitic Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Antiparasitic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Antiparasitic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antiparasitic Drugs Market Segmentation

6.1. Global Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Anthelmintics
Antiprotozoals
Ectoparasiticide
Other Products
6.2. Global Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Avermectins
Bezimidazoles
Pyrimidines
Organophosphates
Imidazolesthiazoles
6.3. Global Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Injectable
Topical
6.4. Global Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users

7. Antiparasitic Drugs Market Regional And Country Analysis

7.1. Global Antiparasitic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Antiparasitic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antiparasitic Drugs Market

8.1. Asia-Pacific Antiparasitic Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antiparasitic Drugs Market

9.1. China Antiparasitic Drugs Market Overview
9.2. China Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antiparasitic Drugs Market

10.1. India Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antiparasitic Drugs Market

11.1. Japan Antiparasitic Drugs Market Overview
11.2. Japan Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antiparasitic Drugs Market

12.1. Australia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antiparasitic Drugs Market

13.1. Indonesia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antiparasitic Drugs Market

14.1. South Korea Antiparasitic Drugs Market Overview
14.2. South Korea Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antiparasitic Drugs Market

15.1. Western Europe Antiparasitic Drugs Market Overview
15.2. Western Europe Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antiparasitic Drugs Market

16.1. UK Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antiparasitic Drugs Market

17.1. Germany Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antiparasitic Drugs Market

18.1. France Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antiparasitic Drugs Market

19.1. Italy Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antiparasitic Drugs Market

20.1. Spain Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antiparasitic Drugs Market

21.1. Eastern Europe Antiparasitic Drugs Market Overview
21.2. Eastern Europe Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antiparasitic Drugs Market

22.1. Russia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antiparasitic Drugs Market

23.1. North America Antiparasitic Drugs Market Overview
23.2. North America Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antiparasitic Drugs Market

24.1. USA Antiparasitic Drugs Market Overview
24.2. USA Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antiparasitic Drugs Market

25.1. Canada Antiparasitic Drugs Market Overview
25.2. Canada Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antiparasitic Drugs Market

26.1. South America Antiparasitic Drugs Market Overview
26.2. South America Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antiparasitic Drugs Market

27.1. Brazil Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antiparasitic Drugs Market

28.1. Middle East Antiparasitic Drugs Market Overview
28.2. Middle East Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antiparasitic Drugs Market

29.1. Africa Antiparasitic Drugs Market Overview
29.2. Africa Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antiparasitic Drugs Market Competitive Landscape And Company Profiles

30.1. Antiparasitic Drugs Market Competitive Landscape
30.2. Antiparasitic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Cadila Pharmaceuticals
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co.Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Antiparasitic Drugs Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Sanofi S.A.
31.3. GlaxoSmithKline plc
31.4. Takeda Pharmaceutical Company Limited
31.5. Boehringer Ingelheim group
31.6. Zoetis Inc.
31.7. Eisai Co. Ltd.
31.8. Covetrus Inc.
31.9. IDEXX Laboratories Inc.
31.10. Dr. Reddy's Laboratories
31.11. Intas Pharmaceuticals Ltd
31.12. Alkem Laboratories Ltd
31.13. Ceva Sante Animale S.A.
31.14. Elanco Animal Health Incorporated
31.15. Phibro Animal Health Corporation

32. Global Antiparasitic Drugs Market Competitive Benchmarking

33. Global Antiparasitic Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Antiparasitic Drugs Market

35. Antiparasitic Drugs Market Future Outlook and Potential Analysis

35.1 Antiparasitic Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Antiparasitic Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Antiparasitic Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer